Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Morbidity and mortality in patients with cardiovascular risk factors and obstructive sleep apnoea: results from the DIAST-CHF cohort.

Haarmann H, Koch J, Bonsch N, Mende M, Werhahn SM, Lüers C, Stahrenberg R, Edelmann F, Holzendorf V, von Haehling S, Pieske B, Andreas S, Lüthje L, Wachter R.

Respir Med. 2019 Jul - Aug;154:127-132. doi: 10.1016/j.rmed.2019.06.019. Epub 2019 Jun 21.

PMID:
31252205
2.

Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial.

Barco S, Schmidtmann I, Ageno W, Bauersachs RM, Becattini C, Bernardi E, Beyer-Westendorf J, Bonacchini L, Brachmann J, Christ M, Czihal M, Duerschmied D, Empen K, Espinola-Klein C, Ficker JH, Fonseca C, Genth-Zotz S, Jiménez D, Harjola VP, Held M, Iogna Prat L, Lange TJ, Manolis A, Meyer A, Mustonen P, Rauch-Kroehnert U, Ruiz-Artacho P, Schellong S, Schwaiblmair M, Stahrenberg R, Westerweel PE, Wild PS, Konstantinides SV, Lankeit M; HoT-PE Investigators .

Eur Heart J. 2019 May 23. pii: ehz367. doi: 10.1093/eurheartj/ehz367. [Epub ahead of print]

PMID:
31120118
3.

Relevance of supraventricular runs detected after cerebral ischemia.

Weber-Krüger M, Lutz C, Zapf A, Stahrenberg R, Seegers J, Witzenhausen J, Wasser K, Hasenfuß G, Gröschel K, Wachter R.

Neurology. 2017 Oct 10;89(15):1545-1552. doi: 10.1212/WNL.0000000000004487. Epub 2017 Sep 13.

PMID:
28904084
4.

Association between Embolic Stroke Patterns, ESUS Etiology, and New Diagnosis of Atrial Fibrillation: A Secondary Data Analysis of the Find-AF Trial.

Maier IL, Schregel K, Karch A, Weber-Krueger M, Mikolajczyk RT, Stahrenberg R, Gröschel K, Bähr M, Knauth M, Psychogios MN, Wachter R, Liman J.

Stroke Res Treat. 2017;2017:1391843. doi: 10.1155/2017/1391843. Epub 2017 Apr 27.

5.

[GDF-15, MRproADM, CTproET1, and CTproAVP in patients with asymptomatic diastolic dysfunction].

Nolte K, Gabriel F, Stahrenberg R, Weber-Krüger M, Herrmann-Lingen C, Hasenfuß G, Wachter R, Edelmann F.

Dtsch Med Wochenschr. 2015 Jun;140(13):e120-8. doi: 10.1055/s-0041-102543. Epub 2015 Jun 26. German.

PMID:
26115140
6.

Determinants of submaximal exercise capacity in patients at risk for heart failure with preserved ejection fraction-results from the DIAST-CHF study.

Stahrenberg R, Duvinage A, Mende M, Gelbrich G, Auf der Heide W, Düngen HD, Binder L, Nolte K, Herrmann-Lingen C, Hasenfuß G, Pieske B, Wachter R, Edelmann F.

ESC Heart Fail. 2015 Jun;2(2):76-84. doi: 10.1002/ehf2.12034. Epub 2015 Apr 27.

7.

Finding atrial fibrillation in stroke patients: Randomized evaluation of enhanced and prolonged Holter monitoring--Find-AF(RANDOMISED) --rationale and design.

Weber-Krüger M, Gelbrich G, Stahrenberg R, Liman J, Kermer P, Hamann GF, Seegers J, Gröschel K, Wachter R; Find-AF(RANDOMISED) investigators.

Am Heart J. 2014 Oct;168(4):438-445.e1. doi: 10.1016/j.ahj.2014.06.018. Epub 2014 Jul 3.

PMID:
25262252
8.

Associations of methylarginines and homoarginine with diastolic dysfunction and cardiovascular risk factors in patients with preserved left ventricular ejection fraction.

Pilz S, Edelmann F, Meinitzer A, Gelbrich G, Döner U, Düngen HD, Tomaschitz A, Kienreich K, Gaksch M, Duvinage A, Stahrenberg R, Kunde J, Schmidt A, März W, Wachter R, Pieske B.

J Card Fail. 2014 Dec;20(12):923-30. doi: 10.1016/j.cardfail.2014.09.004. Epub 2014 Sep 16.

PMID:
25230239
9.

Differential interaction of clinical characteristics with key functional parameters in heart failure with preserved ejection fraction--results of the Aldo-DHF trial.

Edelmann F, Gelbrich G, Duvinage A, Stahrenberg R, Behrens A, Prettin C, Kraigher-Krainer E, Schmidt AG, Düngen HD, Kamke W, Tschöpe C, Herrmann-Lingen C, Halle M, Hasenfuss G, Wachter R, Pieske B.

Int J Cardiol. 2013 Nov 30;169(6):408-17. doi: 10.1016/j.ijcard.2013.10.018. Epub 2013 Oct 11.

10.

Cost-effectiveness of 7-day-Holter monitoring alone or in combination with transthoracic echocardiography in patients with cerebral ischemia.

Mayer F, Stahrenberg R, Gröschel K, Mostardt S, Biermann J, Edelmann F, Liman J, Wasem J, Goehler A, Wachter R, Neumann A.

Clin Res Cardiol. 2013 Dec;102(12):875-84. doi: 10.1007/s00392-013-0601-2. Epub 2013 Aug 2.

11.

Excessive supraventricular ectopic activity is indicative of paroxysmal atrial fibrillation in patients with cerebral ischemia.

Weber-Krüger M, Gröschel K, Mende M, Seegers J, Lahno R, Haase B, Niehaus CF, Edelmann F, Hasenfuß G, Wachter R, Stahrenberg R.

PLoS One. 2013 Jun 28;8(6):e67602. doi: 10.1371/journal.pone.0067602. Print 2013.

12.

Clinical predictors to identify paroxysmal atrial fibrillation after ischaemic stroke.

Wohlfahrt J, Stahrenberg R, Weber-Krüger M, Gröschel S, Wasser K, Edelmann F, Seegers J, Wachter R, Gröschel K.

Eur J Neurol. 2014;21(1):21-7. doi: 10.1111/ene.12198. Epub 2013 May 24.

PMID:
23711185
13.

Age-dependent yield of screening for undetected atrial fibrillation in stroke patients: the Find-AF study.

Wachter R, Weber-Krüger M, Seegers J, Edelmann F, Wohlfahrt J, Wasser K, Gelbrich G, Hasenfuß G, Stahrenberg R, Liman J, Gröschel K.

J Neurol. 2013 Aug;260(8):2042-5. doi: 10.1007/s00415-013-6935-x. Epub 2013 May 1.

14.

Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial.

Edelmann F, Wachter R, Schmidt AG, Kraigher-Krainer E, Colantonio C, Kamke W, Duvinage A, Stahrenberg R, Durstewitz K, Löffler M, Düngen HD, Tschöpe C, Herrmann-Lingen C, Halle M, Hasenfuss G, Gelbrich G, Pieske B; Aldo-DHF Investigators.

JAMA. 2013 Feb 27;309(8):781-91. doi: 10.1001/jama.2013.905.

PMID:
23443441
15.

High-sensitivity troponin assay improves prediction of cardiovascular risk in patients with cerebral ischaemia.

Stahrenberg R, Niehaus CF, Edelmann F, Mende M, Wohlfahrt J, Wasser K, Seegers J, Hasenfuß G, Gröschel K, Wachter R.

J Neurol Neurosurg Psychiatry. 2013 May;84(5):479-87. doi: 10.1136/jnnp-2012-303360. Epub 2013 Jan 25.

16.

Subclinical atrial fibrillation: how hard should we look?

Wachter R, Stahrenberg R, Gröschel K.

Heart. 2013 Feb;99(3):151-3. doi: 10.1136/heartjnl-2012-302248. Epub 2012 Sep 25. No abstract available.

PMID:
23010289
17.

Impact of obstructive sleep apnoea on diastolic function.

Wachter R, Lüthje L, Klemmstein D, Lüers C, Stahrenberg R, Edelmann F, Holzendorf V, Hasenfuß G, Andreas S, Pieske B.

Eur Respir J. 2013 Feb;41(2):376-83. doi: 10.1183/09031936.00218211. Epub 2012 Jul 12.

18.

Natriuretic peptides for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemia--the Find-AF study.

Wachter R, Lahno R, Haase B, Weber-Krüger M, Seegers J, Edelmann F, Wohlfahrt J, Gelbrich G, Görlitz A, Kermer P, Vollmann D, Hasenfuß G, Gröschel K, Stahrenberg R.

PLoS One. 2012;7(4):e34351. doi: 10.1371/journal.pone.0034351. Epub 2012 Apr 11.

19.

Subclinical atrial fibrillation and the risk of stroke.

Wachter R, Stahrenberg R, Gröschel K.

N Engl J Med. 2012 Apr 5;366(14):1350-1; author reply 1352-3. doi: 10.1056/NEJMc1201844. No abstract available.

PMID:
22475606
20.

Growth-differentiation factor-15 and functional outcome after acute ischemic stroke.

Gröschel K, Schnaudigel S, Edelmann F, Niehaus CF, Weber-Krüger M, Haase B, Lahno R, Seegers J, Wasser K, Wohlfahrt J, Vollmann D, Stahrenberg R, Wachter R.

J Neurol. 2012 Aug;259(8):1574-9. doi: 10.1007/s00415-011-6379-0. Epub 2012 Jan 10.

21.

Transthoracic echocardiography to rule out paroxysmal atrial fibrillation as a cause of stroke or transient ischemic attack.

Stahrenberg R, Edelmann F, Haase B, Lahno R, Seegers J, Weber-Krüger M, Mende M, Wohlfahrt J, Kermer P, Vollmann D, Hasenfuss G, Gröschel K, Wachter R.

Stroke. 2011 Dec;42(12):3643-5. doi: 10.1161/STROKEAHA.111.632836. Epub 2011 Oct 13.

PMID:
21998056
22.

Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study.

Edelmann F, Gelbrich G, Düngen HD, Fröhling S, Wachter R, Stahrenberg R, Binder L, Töpper A, Lashki DJ, Schwarz S, Herrmann-Lingen C, Löffler M, Hasenfuss G, Halle M, Pieske B.

J Am Coll Cardiol. 2011 Oct 18;58(17):1780-91. doi: 10.1016/j.jacc.2011.06.054.

23.

Serum aldosterone and its relationship to left ventricular structure and geometry in patients with preserved left ventricular ejection fraction.

Edelmann F, Tomaschitz A, Wachter R, Gelbrich G, Knoke M, Düngen HD, Pilz S, Binder L, Stahrenberg R, Schmidt A, März W, Pieske B.

Eur Heart J. 2012 Jan;33(2):203-12. doi: 10.1093/eurheartj/ehr292. Epub 2011 Aug 19.

PMID:
21856682
24.

[Neurohormonal activation and maximal exercise capacity in diastolic dysfunction and diastolic heart failure].

Edelmann F, Duvinage A, Schwarz S, Stahrenberg R, Wachter R.

Dtsch Med Wochenschr. 2011 Apr;136(16):810-5. doi: 10.1055/s-0031-1275809. Epub 2011 Apr 12. German.

PMID:
21487970
25.

Impaired physical quality of life in patients with diastolic dysfunction associates more strongly with neurohumoral activation than with echocardiographic parameters: quality of life in diastolic dysfunction.

Edelmann F, Stahrenberg R, Polzin F, Kockskämper A, Düngen HD, Duvinage A, Binder L, Kunde J, Scherer M, Gelbrich G, Hasenfuss G, Pieske B, Wachter R, Herrmann-Lingen C.

Am Heart J. 2011 Apr;161(4):797-804. doi: 10.1016/j.ahj.2011.01.003.

PMID:
21473981
26.

Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction.

Edelmann F, Stahrenberg R, Gelbrich G, Durstewitz K, Angermann CE, Düngen HD, Scheffold T, Zugck C, Maisch B, Regitz-Zagrosek V, Hasenfuss G, Pieske BM, Wachter R.

Clin Res Cardiol. 2011 Sep;100(9):755-64. doi: 10.1007/s00392-011-0305-4. Epub 2011 Mar 17.

27.

Heart failure therapy in diabetic patients-comparison with the recent ESC/EASD guideline.

Edelmann F, Wachter R, Düngen HD, Störk S, Richter A, Stahrenberg R, Neumann T, Lüers C, Angermann CE, Mehrhof F, Gelbrich G, Pieske B; German "Competence Network Heart Failure".

Cardiovasc Diabetol. 2011 Feb 8;10:15. doi: 10.1186/1475-2840-10-15.

28.

Letter by Wachter et al regarding article "Cost-effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke".

Wachter R, Stahrenberg R, Gröschel K.

Stroke. 2011 Mar;42(3):e36; author reply e37. doi: 10.1161/STROKEAHA.110.604173. Epub 2011 Jan 27. No abstract available.

PMID:
21273570
29.

Enhanced detection of paroxysmal atrial fibrillation by early and prolonged continuous holter monitoring in patients with cerebral ischemia presenting in sinus rhythm.

Stahrenberg R, Weber-Krüger M, Seegers J, Edelmann F, Lahno R, Haase B, Mende M, Wohlfahrt J, Kermer P, Vollmann D, Hasenfuss G, Gröschel K, Wachter R.

Stroke. 2010 Dec;41(12):2884-8. doi: 10.1161/STROKEAHA.110.591958. Epub 2010 Oct 21.

PMID:
20966415
30.

The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction.

Stahrenberg R, Edelmann F, Mende M, Kockskämper A, Düngen HD, Lüers C, Binder L, Herrmann-Lingen C, Gelbrich G, Hasenfuss G, Pieske B, Wachter R.

Eur J Heart Fail. 2010 Dec;12(12):1309-16. doi: 10.1093/eurjhf/hfq151. Epub 2010 Sep 13.

31.

Association of glucose metabolism with diastolic function along the diabetic continuum.

Stahrenberg R, Edelmann F, Mende M, Kockskämper A, Düngen HD, Scherer M, Kochen MM, Binder L, Herrmann-Lingen C, Schönbrunn L, Gelbrich G, Hasenfuss G, Pieske B, Wachter R.

Diabetologia. 2010 Jul;53(7):1331-40. doi: 10.1007/s00125-010-1718-8. Epub 2010 Apr 13. Erratum in: Diabetologia. 2011 Apr;54(4):990. Schönbrunn, L [added].

32.

A risk score to predict future atrial fibrillation derived from patients with stroke initially presenting with atrial fibrillation?

Stahrenberg R, Wachter R, Gröschel K.

Stroke. 2010 Mar;41(3):e169. doi: 10.1161/STROKEAHA.109.573675. Epub 2010 Feb 4. No abstract available.

PMID:
20133915
33.

Dysfunction of soluble guanylyl cyclase in aorta and kidney of Goto-Kakizaki rats: influence of age and diabetic state.

Witte K, Jacke K, Stahrenberg R, Arlt G, Reitenbach I, Schilling L, Lemmer B.

Nitric Oxide. 2002 Feb;6(1):85-95.

PMID:
11829539
34.

Influence of circadian time, ageing, and hypertension on the urinary excretion of nitric oxide metabolites in rats.

Borgonio A, Witte K, Stahrenberg R, Lemmer B.

Mech Ageing Dev. 1999 Nov 2;111(1):23-37.

PMID:
10576605

Supplemental Content

Loading ...
Support Center